A systematic review of primary active surveillance management of low-risk papillary carcinoma

被引:20
作者
Alhashemi, Ahmad [1 ]
Goldstein, David P. [2 ,3 ]
Sawka, Anna M. [1 ,4 ]
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada
关键词
active surveillance; papillary thyroid cancer; thyroid carcinoma; thyroidectomy; DIFFERENTIATED THYROID-CARCINOMA; THERAPEUTIC STRATEGY; ENDOCRINE SURGEONS; SURGICAL-TREATMENT; JAPANESE SOCIETY; UNITED-STATES; PATIENT AGE; CANCER; MICROCARCINOMA; ASSOCIATION;
D O I
10.1097/CCO.0000000000000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Active surveillance is close follow-up of neoplasms, with predetermined intervention triggers. We systematically reviewed the published English language literature on primary active surveillance of low-risk papillary thyroid cancer (PTC). Recent findings We searched seven electronic databases (1980-2015), supplemented with a hand search. Two reviewers independently screened 1715 citations and reviewed 32 full-text papers, ultimately including two papers. Data were independently abstracted. There were two Japanese single-center, single-arm studies reporting on 1235 and 322 patients with PTC microcarcinoma (primary <1 cm in diameter) confined to the thyroid. Mean study follow-up was of 5.0 and 6.5 years, respectively. Disease triggers for thyroidectomy included progression of the primary tumor or incident metastatic disease. The rates of thyroidectomy were 15.5% (191/1235) and 8.7% (28/322) in respective studies. The incidence of primary tumor enlargement >= 3 mm in maximal diameter was 4.6% (58/1235) and 5.0% (16/322). The incidence of nodal metastases was 1.5% (19/1235) and 0.9% (3/322). There were neither reports of PTC-related death nor development of distant metastatic disease. Quality of life, psychosocial health, and economic outcomes were not reported. Summary In two Japanese single-arm studies, active surveillance of PTC microcarcinoma was relatively well tolerated; however, more long-term outcome research is needed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 54 条
[1]   Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype - Papillary, follicular, and anaplastic: A morphological and epidemiological study [J].
Albores-Saavedra, Jorge ;
Henson, Donald Earl ;
Glazer, Evan ;
Schwartz, Arnold M. .
ENDOCRINE PATHOLOGY, 2007, 18 (01) :1-7
[2]  
[Anonymous], ONCOLOGY TIMES
[3]  
[Anonymous], CANC THYR CANC INC S
[4]  
[Anonymous], 2015 ACT SURV NCI DI
[5]  
[Anonymous], CAN CANC STAT 2014
[6]  
Arem R, 1999, Endocr Pract, V5, P148
[7]   Low risk papillary thyroid cancer [J].
Brito, Juan P. ;
Hay, Ian D. ;
Morris, John C. .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[8]   What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? [J].
Cheema, Yusra ;
Olson, Sarah ;
Elson, Diane ;
Chen, Herbert .
JOURNAL OF SURGICAL RESEARCH, 2006, 134 (02) :160-162
[9]   Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005 [J].
Chen, Amy Y. ;
Jemal, Ahmedin ;
Ward, Elizabeth M. .
CANCER, 2009, 115 (16) :3801-3807
[10]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214